Perioperative Management of Gabapentin and Myotop for NBM Patient
Continue gabapentin on the morning of surgery with a small sip of water, even though the patient is NBM (nil by mouth), as skipping the dose may increase risks of withdrawal seizures, inadequate pain control, and postoperative complications. 1, 2
Gabapentin Perioperative Management
Why Continue Gabapentin
- Gabapentin should be administered preoperatively as part of multimodal opioid-sparing analgesia, with timing optimized to achieve peak effect at surgery onset 1
- The ERAS Society specifically recommends gabapentinoids as pre-anesthetic medication for opioid-sparing effects, administered orally before surgery 1
- Abrupt discontinuation of gabapentin can precipitate withdrawal seizures, even in patients without prior seizure history, particularly in those on chronic therapy 3
- A single preoperative dose of gabapentin (1200 mg) significantly reduces postoperative morphine consumption and pain scores specifically in burn debridement surgery patients 4
Administration Guidelines
- Gabapentin can be taken with a small sip of water (typically 30-50 mL) even when NBM, as this minimal fluid volume does not increase aspiration risk 1
- For debridement surgery, administer gabapentin 2 hours before the procedure to achieve optimal pharmacodynamic effect 1, 4
- The FDA label permits gabapentin administration with or without food, making NBM status not a contraindication 2
Dosing Considerations
- If the patient is on chronic gabapentin therapy, continue the morning dose at the usual prescribed amount 2, 5
- For opioid-sparing in surgery, a single preoperative dose of 1200 mg has proven efficacy in burn wound debridement specifically 4
- Adjust dose if renal impairment is present (creatinine clearance <60 mL/min requires dose reduction per FDA guidelines) 2
Important Safety Considerations
Postoperative Monitoring
- Patients on chronic gabapentin who continue therapy postoperatively have significantly increased risk of requiring naloxone for over-sedation or respiratory depression (OR 6.30,95% CI 2.4-16.7) 5
- Elderly patients (≥65 years) receiving perioperative gabapentin have increased risk of delirium (RR 1.28), new antipsychotic use (RR 1.17), and pneumonia (RR 1.11) 6
- Enhanced postoperative monitoring is warranted, particularly for patients with obstructive sleep apnea, high comorbidity burden, or chronic kidney disease 5, 6
Withdrawal Risk
- Missing even 2 days of gabapentin in patients on chronic high-dose therapy can precipitate status epilepticus, as documented in a patient on 8000 mg/day 3
- Gabapentin discontinuation should be gradual over minimum 1 week, not abrupt 2
Myotop (Muscle Relaxant) Management
The morning dose of myotop can be safely skipped for NBM status, as:
- Muscle relaxants are not part of evidence-based perioperative protocols and are not mentioned in ERAS guidelines 1
- Unlike gabapentin, muscle relaxants do not have documented withdrawal seizure risk and are not critical for multimodal analgesia 1
- Muscle relaxants may contribute to postoperative sedation without clear analgesic benefit 1
Clinical Algorithm
- Verify patient's chronic gabapentin dose and indication (pain vs. seizure disorder)
- Check renal function - adjust gabapentin dose if CrCl <60 mL/min 2
- Administer gabapentin 2 hours preoperatively with small sip of water (30-50 mL) 1, 4
- Hold myotop on morning of surgery - not essential for perioperative care 1
- Arrange enhanced postoperative monitoring if patient is elderly, has OSA, or high comorbidity burden 5, 6
- Resume gabapentin postoperatively cautiously, recognizing increased naloxone risk with continuation 5
Common Pitfalls to Avoid
- Do not withhold gabapentin due to NBM status - the small amount of water needed poses negligible aspiration risk 1, 2
- Do not assume all oral medications must be held NBM - critical medications like gabapentin should continue 1
- Do not underestimate withdrawal risk - even short interruptions can cause seizures in chronic users 3
- Do not overlook renal dosing adjustments - gabapentin is renally cleared and requires dose reduction in renal impairment 2